From: Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast
Variables | No. of cases | Tiam1 strongly positive cases (%) | χ 2 | P value |
---|---|---|---|---|
Age | Â | Â | 0.186 | 0.666 |
 ≥ 50 | 84 | 37 (44.0 %) |  |  |
 < 50 | 69 | 28 (40.6 %) | ||
Menopausal status | Â | Â | 1.981 | 0.159 |
 Premenopausal | 63 | 31 (49.2 %) |  |  |
 Postmenopausal | 90 | 34 (37.8 %) | ||
Molecular type | Â | Â | 5.142 | 0.162 |
 Luminal A | 39 | 21 (53.8 %) |  |  |
 Luminal B | 46 | 21 (45.7 %) | ||
 TNBC | 39 | 15 (35.9 %) | ||
 Her2+ | 29 | 8 (27.6 %) | ||
Tumor stage | Â | Â | 10.136 | 0.002** |
 T0-T1 | 84 | 26 (31.0 %) |  |  |
 T2-T3 | 69 | 39 (56.5 %) | ||
LN metastasis | Â | Â | 0.364 | 0.546 |
 Absent | 57 | 26 (45.6 %) |  |  |
 Presence | 96 | 39 (40.6 %) | ||
ER | Â | Â | 0.453 | 0.501 |
 Positive | 87 | 39 (44.8 %) |  |  |
 Negative | 66 | 26 (39.4 %) | ||
PR | Â | Â | 0.489 | 0.484 |
 Positive | 78 | 31 (39.7 %) |  |  |
 Negative | 75 | 34 (45.3 %) | ||
Her2 | Â | Â | 4.003 | 0.046* |
 Positive | 41 | 12 (29.3 %) |  |  |
 Negative | 112 | 53 (47.3 %) | ||
Ki-67 | Â | Â | 7.075 | 0.008** |
 Positive | 102 | 51 (50.0 %) |  |  |
 Negative | 51 | 14 (27.5 %) |